Ulcer Disease in the Excluded Segments after Roux-en-Y Gastric Bypass: a Current Review of the Literature
| Autor: | Gabriel Andreas Plitzko, Yves Michael Borbély, Dino Kröll, Philipp C. Nett, Gregoire Schmutz |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Peptic Ulcer Endocrinology Diabetes and Metabolism medicine.medical_treatment Gastric Bypass Hemorrhage 610 Medicine & health Review Gastric remnant Morbid obesity Peptic Ulcer Perforation Pneumoperitoneum Gastrectomy medicine Humans Ulcer Anti-inflammatory agents Gastrostomy Nutrition and Dietetics biology business.industry Peptic ulcer perforation Helicobacter pylori medicine.disease biology.organism_classification Roux-en-Y anastomosis Surgery Obesity Morbid medicine.anatomical_structure Gastritis Duodenum Roux-Y gastric bypass medicine.symptom business Non-steroidal anti-inflammatory drugs |
| Zdroj: | Plitzko, Gabriel Andreas; Schmutz, Grégoire; Kröll, Dino; Nett, Philipp C.; Borbély, Yves (2021). Ulcer Disease in the Excluded Segments after Roux-en-Y Gastric Bypass: a Current Review of the Literature. Obesity surgery, 31(3), pp. 1280-1289. Springer-Verlag 10.1007/s11695-020-05123-w Obesity Surgery |
| DOI: | 10.1007/s11695-020-05123-w |
| Popis: | Ulcer disease in excluded segments after Roux-Y gastric bypass (RYGB) is rare but can evolve into a life-threatening situation. The excluded segments exhibit a different behavior from that of non-altered anatomy; perforated ulcers do not result in pneumoperitoneum or free fluid, and therefore must be met with a low threshold for surgical exploration. The anatomical changes after RYGB impede routine access to the remnant stomach and duodenum. There are various options to address bleeding or perforated ulcers. While oversewing and drainage preserves the anatomy and forgoes resection, remnant gastrectomy offers a definitive solution. The importance of traditional risk factors such as smoking or use of non-steroidal anti-inflammatory drugs is unclear. Eradication ofHelicobacter pyloriand secondary prophylaxis with proton-pump inhibitors is advisable, albeit in double-dose. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|